Pharmacokinetics, Safety, and Tolerability of Doripenem After 0.5‐, 1‐, and 4‐Hour Infusions in Healthy Volunteers
2009 · The Journal of Clinical Pharmacology · 50 citations
https://doi.org/10.1177/0091270009337012
K
K. C. Turner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
100
Papers
3.7K
Citations
23
h-index
35
i10-index
K. C. Turner is an academic researcher from Regeneron (United States). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Astronomy and Astrophysical Research. The author has an h-index of 23, co-authored 85 publications.
Papers by this author
worksOperational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials
2020 · Contemporary Clinical Trials Communications · 36 citations
https://doi.org/10.1016/j.conctc.2020.100532
Population Pharmacokinetics of Casirivimab and Imdevimab in Pediatric and Adult Non-Infected Individuals, Pediatric and Adult Ambulatory or Hospitalized Patients or Household Contacts of Patients Infected with SARS-COV-2
2024 · Pharmaceutical Research · 2 citations
https://doi.org/10.1007/s11095-024-03764-5
The Effects of Fasinumab on Peripheral Nerve Function and Ganglion Anatomy: Results From a Randomized, Double-Blind, Placebo-Controlled Study in Patients With Pain Due to Osteoarthritis of the Knee or Hip, and a Series of Nonclinical Studies
2025 · Current Therapeutic Research · 0 citations
https://doi.org/10.1016/j.curtheres.2025.100813
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat